Residual Platelet Reactivity Risky in ACS

EuroPCR 2011 — PARIS — A poor response to clopidogrel (Plavix) during percutaneous coronary intervention (PCI) can predict poor outcomes in patients with acute coronary syndrome, an Italian study found.


< Back to Listings